Detalhe da pesquisa
1.
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7.
Lab Invest
; 104(4): 100321, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38154497
2.
Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center.
Int J Mol Sci
; 25(4)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397025
3.
Galectin-10 Expression in Placentas of Women with Gestational Diabetes.
Curr Issues Mol Biol
; 45(11): 8840-8851, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37998731
4.
Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database.
J Surg Oncol
; 128(1): 111-118, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975108
5.
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy.
Int J Gynecol Cancer
; 33(5): 812-822, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707086
6.
Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in BRCA1/2: results of the observational AGO-TR1 study (NCT02222883).
J Med Genet
; 59(3): 248-252, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33273034
7.
Risk of postpartum depressive symptoms is influenced by psychological burden related to the COVID-19 pandemic and dependent of individual stress coping.
Arch Gynecol Obstet
; 308(6): 1737-1748, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482113
8.
Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany.
Arch Gynecol Obstet
; 307(1): 129-137, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068363
9.
PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer.
Int J Mol Sci
; 24(1)2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36614323
10.
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
N Engl J Med
; 381(25): 2416-2428, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851799
11.
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.
N Engl J Med
; 380(9): 822-832, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30811909
12.
Clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
Gynecol Oncol
; 166(3): 576-581, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764443
13.
Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany.
Arch Gynecol Obstet
; 305(3): 713-718, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34491417
14.
Galectin-8 and -9 as prognostic factors for cervical cancer.
Arch Gynecol Obstet
; 306(4): 1211-1220, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377045
15.
The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer.
Arch Gynecol Obstet
; 305(6): 1559-1572, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34870752
16.
The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT database of the AGO study group.
Arch Gynecol Obstet
; 304(6): 1541-1549, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34287678
17.
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
Arch Gynecol Obstet
; 303(5): 1331-1345, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277683
18.
Sirtuin 1 and Sirtuin 3 in Granulosa Cell Tumors.
Int J Mol Sci
; 22(4)2021 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33669567
19.
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.
Int J Cancer
; 146(2): 439-448, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31381147
20.
Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.
Histochem Cell Biol
; 154(4): 421-429, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32572587